CARM: Carisma Therapeutics Inc Financial Statements
Balance sheet, income statement, and cash flow statements for Carisma Therapeutics Inc (CARM).
$17.48M Market Cap.
CARM Market Cap. (MRY)
CARM Shares Outstanding (MRY)
CARM Assets (MRY)
Total Assets
$30.46M
Total Liabilities
$58.37M
Total Investments
$0
CARM Income (MRY)
Revenue
$19.63M
Net Income
-$60.48M
Operating Expense
$81.81M
CARM Cash Flow (MRY)
CF Operations
-$59.92M
CF Investing
-$123.00K
CF Financing
$344.00K
CARM Balance Sheet (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Total Assets | $30,458,000 (-65.99%) | $89,554,000 (24.12%) | $72,153,000 (-70.03%) | $240,747,000 (96.01%) |
Assets Current | $23,825,000 (-70.39%) | $80,471,000 (47.40%) | $54,592,000 (-73.45%) | $205,605,000 (227.05%) |
Assets Non-Current | $6,633,000 (-26.97%) | $9,083,000 (-48.28%) | $17,561,000 (-50.03%) | $35,142,000 (-41.39%) |
Goodwill & Intangible Assets | $0 (0%) | $0 (0%) | $0 (0%) | $27,764,000 (-53.31%) |
Shareholders Equity | -$27,909,000 (-205.19%) | $26,532,000 (116.89%) | -$157,065,000 (-191.47%) | $171,710,000 (1960.95%) |
Property Plant & Equipment Net | $6,425,000 (-28.11%) | $8,937,000 (-33.55%) | $13,450,000 (31179.07%) | $43,000 (-65.04%) |
Cash & Equivalents | $17,909,000 (-76.92%) | $77,605,000 (220.76%) | $24,194,000 (-85.12%) | $162,636,000 (193.63%) |
Accumulated Other Comprehensive Income | $0 (0%) | $0 (0%) | -$41,000 (0%) | $0 (0%) |
Deferred Revenue | $44,979,000 (-3.09%) | $46,413,000 (-2.20%) | $47,459,000 (3063.93%) | $1,500,000 (-50.00%) |
Total Investments | $0 (0%) | $0 (0%) | $27,802,000 (138910.00%) | $20,000 (0.00%) |
Investments Current | $0 (0%) | $0 (0%) | $27,802,000 (0%) | $0 (0%) |
Investments Non-Current | $0 (0%) | $0 (0%) | $0 (0%) | $20,000 (0.00%) |
Inventory | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Trade & Non-Trade Receivables | $0 (0%) | $0 (0%) | $0 (0%) | $24,493,000 (0%) |
Trade & Non-Trade Payables | $2,081,000 (-47.09%) | $3,933,000 (127.60%) | $1,728,000 (-39.43%) | $2,853,000 (-8.03%) |
Accumulated Retained Earnings (Deficit) | -$305,579,000 (-24.67%) | -$245,102,000 (-54.91%) | -$158,223,000 (49.97%) | -$316,257,000 (-0.11%) |
Tax Assets | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Tax Liabilities | $0 (0%) | $0 (0%) | $0 (0%) | $3,969,000 (-68.32%) |
Total Debt | $2,481,000 (-20.56%) | $3,123,000 (-92.22%) | $40,164,000 (0%) | $0 (0%) |
Debt Current | $1,737,000 (-10.23%) | $1,935,000 (-57.93%) | $4,599,000 (0%) | $0 (0%) |
Debt Non-Current | $744,000 (-37.37%) | $1,188,000 (-96.66%) | $35,565,000 (0%) | $0 (0%) |
Total Liabilities | $58,367,000 (-7.39%) | $63,022,000 (-41.11%) | $107,015,000 (55.01%) | $69,037,000 (-47.72%) |
Liabilities Current | $16,055,000 (0.92%) | $15,908,000 (-19.13%) | $19,670,000 (70.04%) | $11,568,000 (-35.91%) |
Liabilities Non-Current | $42,312,000 (-10.19%) | $47,114,000 (-46.06%) | $87,345,000 (51.99%) | $57,469,000 (-49.59%) |
CARM Income Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Revenues | $19,632,000 (31.59%) | $14,919,000 (51.71%) | $9,834,000 (-62.95%) | $26,544,000 (136.24%) |
Cost of Revenue | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Selling General & Administrative Expense | $22,138,000 (-25.02%) | $29,525,000 (214.83%) | $9,378,000 (-68.09%) | $29,393,000 (105.52%) |
Research & Development Expense | $59,673,000 (-19.50%) | $74,125,000 (30.92%) | $56,618,000 (123.68%) | $25,312,000 (-13.29%) |
Operating Expenses | $81,811,000 (-21.07%) | $103,650,000 (57.05%) | $65,996,000 (-28.21%) | $91,933,000 (111.37%) |
Interest Expense | $0 (0%) | $0 (0%) | $3,145,000 (0%) | $0 (0%) |
Income Tax Expense | $0 (0%) | $0 (0%) | $0 (0%) | -$8,273,000 (-672.53%) |
Net Loss Income from Discontinued Operations | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Consolidated Income | -$60,477,000 (30.39%) | -$86,879,000 (-41.90%) | -$61,226,000 (-18122.02%) | -$336,000 (98.50%) |
Net Income to Non-Controlling Interests | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Income | -$60,477,000 (30.39%) | -$86,879,000 (-41.90%) | -$61,226,000 (-18122.02%) | -$336,000 (98.50%) |
Preferred Dividends Income Statement Impact | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Income Common Stock | -$60,477,000 (30.39%) | -$86,879,000 (-41.90%) | -$61,226,000 (-18122.02%) | -$336,000 (98.51%) |
Weighted Average Shares | $41,456,210 (23.66%) | $33,524,197 (1475.33%) | $2,128,069 (-76.66%) | $9,116,150 (54.22%) |
Weighted Average Shares Diluted | $41,456,210 (23.66%) | $33,524,197 (1475.33%) | $2,128,069 (-76.66%) | $9,116,150 (54.22%) |
Earning Before Interest & Taxes (EBIT) | -$60,477,000 (30.39%) | -$86,879,000 (-49.58%) | -$58,081,000 (-574.65%) | -$8,609,000 (58.91%) |
Gross Profit | $19,632,000 (31.59%) | $14,919,000 (51.71%) | $9,834,000 (-62.95%) | $26,544,000 (136.24%) |
Operating Income | -$62,179,000 (29.92%) | -$88,731,000 (-57.99%) | -$56,162,000 (14.11%) | -$65,389,000 (-102.71%) |
CARM Cash Flow Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Net Cash Flow from Investing | -$123,000 (-100.17%) | $72,408,000 (322.38%) | -$32,560,000 (-813900.00%) | -$4,000 (50.00%) |
Net Cash Flow from Financing | $344,000 (-99.45%) | $62,180,000 (86.62%) | $33,319,000 (-81.08%) | $176,129,000 (362.12%) |
Net Cash Flow from Operations | -$59,917,000 (26.19%) | -$81,177,000 (-1486.73%) | -$5,116,000 (92.57%) | -$68,878,000 (-123.36%) |
Net Cash Flow / Change in Cash & Cash Equivalents | -$59,696,000 (-211.77%) | $53,411,000 (1325.87%) | -$4,357,000 (-104.06%) | $107,247,000 (1375.61%) |
Net Cash Flow - Business Acquisitions and Disposals | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Cash Flow - Investment Acquisitions and Disposals | $0 (0%) | $73,540,000 (363.58%) | -$27,900,000 (0%) | $0 (0%) |
Capital Expenditure | -$123,000 (89.13%) | -$1,132,000 (75.71%) | -$4,660,000 (-116400.00%) | -$4,000 (50.00%) |
Issuance (Repayment) of Debt Securities | -$2,052,000 (-53.94%) | -$1,333,000 (-104.01%) | $33,213,000 (0%) | $0 (0%) |
Issuance (Purchase) of Equity Shares | $2,396,000 (-92.38%) | $31,424,000 (29545.28%) | $106,000 (-99.94%) | $176,130,000 (362.26%) |
Payment of Dividends & Other Cash Distributions | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Effect of Exchange Rate Changes on Cash | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Share Based Compensation | $3,649,000 (57.56%) | $2,316,000 (742.18%) | $275,000 (-94.65%) | $5,143,000 (192.71%) |
Depreciation Amortization & Accretion | $8,317,000 (0.63%) | $8,265,000 (35.71%) | $6,090,000 (7064.71%) | $85,000 (-30.33%) |
CARM Financial Metrics (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Gross Margin | 100.00% (0.00%) | 100.00% (0.00%) | 100.00% (0.00%) | 100.00% (0.00%) |
Profit Margin | -308.10% (47.09%) | -582.30% (6.47%) | -622.60% (-47792.31%) | -1.30% (99.35%) |
EBITDA Margin | -265.70% (49.57%) | -526.90% (0.34%) | -528.70% (-1547.04%) | -32.10% (82.69%) |
Return on Average Equity (ROAE) | 870.80% (665.45%) | -154.00% (-103.17%) | -75.80% (-25166.67%) | -0.30% (-100.03%) |
Return on Average Assets (ROAA) | -117.60% (-64.25%) | -71.60% (-97.25%) | -36.30% (-36200.00%) | -0.10% (99.51%) |
Return on Sales (ROS) | -308.10% (47.09%) | -582.30% (1.41%) | -590.60% (-1722.84%) | -32.40% (82.63%) |
Return on Invested Capital (ROIC) | -942.70% (-262.86%) | -259.80% (-184.25%) | -91.40% (-86.15%) | -49.10% (-111.36%) |
Dividend Yield | 0% (0%) | 12.30% (0%) | 0% (0%) | 0% (0%) |
Price to Earnings Ratio (P/E) | -0.29 (74.62%) | -1.13 (-166.75%) | -0.42 | - |
Price to Sales Ratio (P/S) | 0.88 (-86.57%) | 6.58 (149.58%) | 2.64 (-52.88%) | 5.6 (-60.59%) |
Price to Book Ratio (P/B) | -0.63 (-114.05%) | 4.46 (666.33%) | -0.79 (-183.10%) | 0.95 (105.00%) |
Debt to Equity Ratio (D/E) | -2.09 (-188.04%) | 2.38 (448.75%) | -0.68 (-269.40%) | 0.4 (102.81%) |
Earnings Per Share (EPS) | -1.46 (43.63%) | -2.59 (91.00%) | -28.77 (0%) | 0 (0%) |
Sales Per Share (SPS) | 0.47 (6.52%) | 0.45 (-90.37%) | 4.62 (58.69%) | 2.91 (53.18%) |
Free Cash Flow Per Share (FCFPS) | -1.45 (41.02%) | -2.46 (46.56%) | -4.59 (39.20%) | -7.56 (-44.81%) |
Book Value Per Share (BVPS) | -0.67 (-185.08%) | 0.79 (101.07%) | -73.81 (-491.83%) | 18.84 (1306.66%) |
Tangible Assets Book Value Per Share (TABVPS) | 0.73 (-72.48%) | 2.67 (-92.12%) | 33.91 (45.12%) | 23.36 (117.96%) |
Enterprise Value Over EBIT (EV/EBIT) | 0 (0%) | 0 (0%) | -1 (-200.00%) | 1 (116.67%) |
Enterprise Value Over EBITDA (EV/EBITDA) | 0.12 (124.32%) | -0.48 (52.33%) | -1.01 (-167.85%) | 1.49 (123.35%) |
Asset Turnover | 0.38 (210.57%) | 0.12 (112.07%) | 0.06 (-50.43%) | 0.12 (13.59%) |
Current Ratio | 1.48 (-70.67%) | 5.06 (82.31%) | 2.77 (-84.39%) | 17.77 (410.31%) |
Dividends | $0 (0%) | $0.36 (0%) | $0 (0%) | $0 (0%) |
Free Cash Flow (FCF) | -$60,040,000 (27.06%) | -$82,309,000 (-741.95%) | -$9,776,000 (85.81%) | -$68,882,000 (-123.32%) |
Enterprise Value (EV) | -$6,079,054 (-116.07%) | $37,830,442 (-27.91%) | $52,473,399 (514.05%) | -$12,673,129 (-109.56%) |
Earnings Before Tax (EBT) | -$60,477,000 (30.39%) | -$86,879,000 (-41.90%) | -$61,226,000 (-611.19%) | -$8,609,000 (58.91%) |
Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | -$52,160,000 (33.65%) | -$78,614,000 (-51.21%) | -$51,991,000 (-509.94%) | -$8,524,000 (59.08%) |
Invested Capital | -$1,025,000 (-22.61%) | -$836,000 (-101.22%) | $68,453,000 (76.52%) | $38,779,000 (484.75%) |
Working Capital | $7,770,000 (-87.97%) | $64,563,000 (84.88%) | $34,922,000 (-82.00%) | $194,037,000 (332.94%) |
Tangible Asset Value | $30,458,000 (-65.99%) | $89,554,000 (24.12%) | $72,153,000 (-66.12%) | $212,983,000 (236.15%) |
Market Capitalization | $17,484,946 (-85.21%) | $118,245,442 (-4.32%) | $123,580,399 (-23.98%) | $162,562,871 (-6.90%) |
Average Equity | -$6,945,000 (-112.31%) | $56,401,250 (-30.18%) | $80,779,750 (-17.43%) | $97,834,250 (4030.27%) |
Average Assets | $51,412,500 (-57.64%) | $121,370,750 (-27.96%) | $168,470,000 (-25.45%) | $225,969,750 (106.49%) |
Invested Capital Average | $6,415,250 (-80.82%) | $33,446,750 (-47.38%) | $63,563,750 (262.32%) | $17,543,500 (462.00%) |
Shares | 41,750,109 (3.45%) | 40,356,806 (298.08%) | 10,137,851 (1.65%) | 9,973,182 (54.22%) |
